Publications
Specialty
Search
Lymphoma, Leukemia & Myeloma Network, Oncology
10/25/2024
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Bruno Paiva, PhD, shared expert insight into the immune determinants of response and resistance among patients with multiple myeloma, highlighting the need to bring immune biomarkers into the clinic.
Journal of Clinical Pathways
10/25/2024
Learn about recent advancements in CLL treatment including the potential approval of new combination therapies and the evolving landscape of targeted therapies.
EP Lab Digest
10/25/2024
Medtronic Press Release
GALWAY, Ireland, Oct. 24, 2024 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter, an all-in-one, high-density (HD) mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter for treatment of persistent atrial fibrillation (AFib) and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/25/2024
With this decision, five of the seven Medicare Administrative Contractors (MACs) will soon provide coverage for AI-enabled quantitative coronary plaque analysis, expanding accessibility to over 70 percent of eligible Medicare patients across the United States.
First Report Managed Care
10/25/2024
Recent advancements in the treatment of pulmonary arterial hypertension have shifted clinical practices toward combination therapies, particularly highlighting the role of riociguat.
Cath Lab Digest, Journal of Invasive Cardiology, Vascular Disease Management, CardioVascular
10/25/2024
“The unique maneuverability of the large-bore Vertex endoportal device enabled us to easily navigate across multiple bends through the right heart and into the pulmonary arteries," said Mitchell Weinberg, MD.
Advances in Inflammatory Bowel Disease Network
10/25/2024
Dr Ashburn explains the surgical techniques that can help relieve pain and promote healing for patients with perianal and fistulizing Crohn's disease.
Journal of Clinical Pathways
10/25/2024
Abemaciclib, a CDK4/6 inhibitor used in breast cancer treatment, shows promise in targeting novel mechanisms in endometrial cancer for potential therapeutic benefits in cases of recurrence, particularly in estrogen receptor-positive patients.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/25/2024
The latest Evolut FX+ TAVI system offers three larger coronary access windows through a modified diamond-shaped frame design, which are four times larger than regular cells of the Evolut TAVI system.
Annals of Long-Term Care
10/25/2024
Personalized adaptive deep brain stimulation may offer better control of motor symptoms and enhance quality of life compared to standard treatment approaches in Parkinson disease.
Vascular Disease Management, CardioVascular
10/25/2024
Observations suggest that up to 8% of individuals initially diagnosed with suspected subclavian steal syndrome may present with innominate artery lesions.
Journal of Invasive Cardiology, CardioVascular
10/25/2024
In this review, the authors assessed the clinical outcomes of transcatheter aortic valve replacement, as an alternative to surgical aortic valve replacement , in pregnant women with severe aortic stenosis with a focus on the potential benefits and limitations of this technique.
Veterans Health Today
10/25/2024
New targeted therapies and immunotherapy improve outcomes in upper tract urothelial carcinoma.
First Report Managed Care
10/25/2024
Researchers examined the risk of disease activity in patients with multiple sclerosis after discontinuing disease-modifying drugs.
First Report Managed Care
10/25/2024
The OCARINA II study demonstrates that subcutaneous ocrelizumab is noninferior to intravenous administration in efficacy and safety for treating relapsing and primary progressive multiple sclerosis.
Journal of Invasive Cardiology, CardioVascular
10/24/2024
The authors conducted an international, online survey of attending cardiologists to assess their financial well-being.
First Report Managed Care
10/24/2024
In this interview, Trushar Dungarani, DO, SFHM, discusses the importance of high-quality, accessible patient data for clinicians to enhance care delivery, address social determinants of health, and drive effective population health initiatives.
EP Lab Digest
10/24/2024
Adagio Medical Holdings, Inc., announces the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio’s VT Cryoablation System.
Vascular Disease Management, CardioVascular
10/24/2024
Both companies also join the newly established World Stroke Organization Advocacy Coalition
Oncology, Lymphoma, Leukemia & Myeloma Network
10/24/2024
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Jonathan Canaani, MD, discusses advancements in risk stratification and prognosis among patients with acute myeloid leukemia.